Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA PROPOSED PHYSICIAN LABELING REVISIONS WILL BE TESTED WITH 480 MDs: PUBLIC WORKSHOP ON LABELING CHANGES MAY BE CONVENED BY AGENCY THIS SUMMER

Executive Summary

An FDA contractor is slated to conduct a quantitative study of the reaction of 480 health care professionals to new formats of drug labeling. The health care professionals will be given drug labeling mock-ups by National Biosystems and asked about format preferences.
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

PS026184

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel